Bill Sponsors: TN HB2002 | 2017-2018 | 110th General Assembly

Bill Title: As enacted, permits the direct administration of buprenorphine mono or buprenorphine without the use of naloxone as a treatment for substance use disorder under certain circumstances. - Amends TCA Title 53, Chapter 10; Title 53, Chapter 11 and Title 63.

Spectrum: Moderate Partisan Bill (Republican 6-1)

Status: (Passed) 2018-04-17 - Pub. Ch. 674 [HB2002 Detail]

Text: Latest bill text (Chaptered) [PDF]

Sponsors

NameTypeSponsorshipDistrictFinancialEncyclopediaBiography
Representative Bryan Terry [R]PrimarySponsored BillsHD-048FollowTheMoneyBallotpediaVoteSmart
Representative David Hawk [R]CosponsorSponsored BillsHD-005FollowTheMoneyBallotpediaVoteSmart
Representative Cameron Sexton [R]CosponsorSponsored BillsHD-025FollowTheMoneyBallotpediaVoteSmart
Representative Sabi Kumar [R]CosponsorSponsored BillsHD-066FollowTheMoneyBallotpediaVoteSmart
Representative JoAnne Favors [D]CosponsorSponsored BillsHD-028FollowTheMoneyBallotpediaVoteSmart
Representative John Ragan [R]CosponsorSponsored BillsHD-033FollowTheMoneyBallotpediaVoteSmart
Representative Dennis Powers [R]CosponsorSponsored BillsHD-036FollowTheMoneyBallotpediaVoteSmart

Social Comments on TN HB2002

feedback